P
4.77
0.17 (3.70%)
| 前收盘价格 | 4.60 |
| 收盘价格 | 4.70 |
| 成交量 | 1,927,803 |
| 平均成交量 (3个月) | 1,195,808 |
| 市值 | 256,754,784 |
| 价格/销量 (P/S) | 1.79 |
| 股市价格/股市净资产 (P/B) | 0.570 |
| 52周波幅 | |
| 利润日期 | 6 Aug 2025 - 11 Aug 2025 |
| 营业毛利率 | -79.94% |
| 营业利益率 (TTM) | -2,318.99% |
| 稀释每股收益 (EPS TTM) | -2.05 |
| 季度收入增长率 (YOY) | 5,556.00% |
| 总债务/股东权益 (D/E MRQ) | 2.33% |
| 流动比率 (MRQ) | 9.00 |
| 营业现金流 (OCF TTM) | -130.36 M |
| 杠杆自由现金流 (LFCF TTM) | -35.38 M |
| 资产报酬率 (ROA TTM) | -15.49% |
| 股东权益报酬率 (ROE TTM) | -23.46% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Prothena Corporation plc | 看跌 | 看跌 |
AIStockmoo 评分
1.8
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.75 |
|
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer’s disease (PRX123), Neurodegeneration (PRXPRX019), and Others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 19.01% |
| 机构持股比例 | 88.20% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 81.00 (Piper Sandler, 1,598.11%) | 购买 |
| 中 | 18.00 (277.36%) | |
| 低 | 4.00 (B of A Securities, -16.14%) | 卖出 |
| 平均值 | 29.20 (512.16%) | |
| 总计 | 4 购买, 1 卖出 | |
| 平均价格@调整类型 | 4.58 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| B of A Securities | 28 May 2025 | 4.00 (-16.14%) | 卖出 | 4.60 |
| Chardan Capital | 27 May 2025 | 18.00 (277.36%) | 购买 | 4.58 |
| 09 May 2025 | 40.00 (738.57%) | 购买 | 7.43 | |
| HC Wainwright & Co. | 27 May 2025 | 14.00 (193.50%) | 购买 | 4.58 |
| 09 May 2025 | 30.00 (528.93%) | 购买 | 7.43 | |
| JMP Securities | 27 May 2025 | 29.00 (507.97%) | 购买 | 4.58 |
| 09 May 2025 | 78.00 (1,535.22%) | 购买 | 7.43 | |
| Piper Sandler | 27 May 2025 | 81.00 (1,598.11%) | 购买 | 4.58 |
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 08 May 2025 | 公告 | Prothena Reports First Quarter 2025 Financial Results and Business Highlights |
| 01 May 2025 | 公告 | Prothena to Report First Quarter 2025 Financial Results on May 8 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合